Express Scripts Holding Company (NASDAQ:ESRX) – Investment analysts at Oppenheimer Holdings boosted their FY2017 EPS estimates for shares of Express Scripts Holding in a research note issued on Wednesday, Zacks Investment Research reports. Oppenheimer Holdings analyst M. Naidu now expects that the company will earn $7.02 per share for the year, up from their previous forecast of $6.99. Oppenheimer Holdings also issued estimates for Express Scripts Holding’s Q4 2017 earnings at $2.05 EPS, Q1 2018 earnings at $1.51 EPS, Q2 2018 earnings at $1.86 EPS, Q3 2018 earnings at $2.04 EPS and Q4 2018 earnings at $2.26 EPS.
Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, hitting analysts’ consensus estimates of $1.90. Express Scripts Holding had a net margin of 3.64% and a return on equity of 25.46%. The firm had revenue of $24.68 billion for the quarter, compared to the consensus estimate of $25.68 billion. During the same quarter in the previous year, the firm earned $1.74 earnings per share. The firm’s revenue was down 2.9% on a year-over-year basis.
COPYRIGHT VIOLATION WARNING: “Oppenheimer Holdings Research Analysts Boost Earnings Estimates for Express Scripts Holding Company (NASDAQ:ESRX)” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2017/11/11/fy2017-earnings-forecast-for-express-scripts-holding-company-esrx-issued-by-oppenheimer-holdings.html.
Other equities analysts have also issued research reports about the stock. Robert W. Baird increased their target price on shares of Express Scripts Holding from $57.00 to $59.00 and gave the company a “neutral” rating in a research report on Wednesday, October 25th. Jefferies Group LLC set a $72.00 target price on shares of Express Scripts Holding and gave the stock a “buy” rating in a report on Tuesday, August 29th. Zacks Investment Research downgraded Express Scripts Holding from a “buy” rating to a “sell” rating in a report on Tuesday, October 24th. Royal Bank of Canada set a $66.00 price objective on shares of Express Scripts Holding and gave the stock a “hold” rating in a research note on Wednesday, October 25th. Finally, UBS AG cut Express Scripts Holding from a “market perform” rating to an “underperform” rating in a report on Monday, October 9th. Seven analysts have rated the stock with a sell rating, ten have issued a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $69.53.
Shares of Express Scripts Holding (NASDAQ:ESRX) traded down $0.70 during mid-day trading on Thursday, reaching $60.05. 3,608,400 shares of the company traded hands, compared to its average volume of 4,115,587. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. Express Scripts Holding has a 1 year low of $55.80 and a 1 year high of $77.50. The firm has a market capitalization of $34,407.16, a price-to-earnings ratio of 8.88, a price-to-earnings-growth ratio of 0.90 and a beta of 0.88.
Several institutional investors and hedge funds have recently bought and sold shares of ESRX. Waldron LP purchased a new position in shares of Express Scripts Holding in the 1st quarter worth about $206,000. Lingohr & Partner Asset Management GmbH bought a new stake in shares of Express Scripts Holding in the 1st quarter valued at about $758,000. 1st Global Advisors Inc. lifted its stake in shares of Express Scripts Holding by 22.9% in the 1st quarter. 1st Global Advisors Inc. now owns 9,963 shares of the company’s stock valued at $657,000 after acquiring an additional 1,855 shares during the last quarter. Shufro Rose & Co. LLC lifted its stake in shares of Express Scripts Holding by 43.1% in the 1st quarter. Shufro Rose & Co. LLC now owns 22,374 shares of the company’s stock valued at $1,475,000 after acquiring an additional 6,741 shares during the last quarter. Finally, Hancock Holding Co. lifted its stake in shares of Express Scripts Holding by 9.9% in the 1st quarter. Hancock Holding Co. now owns 183,489 shares of the company’s stock valued at $12,094,000 after acquiring an additional 16,536 shares during the last quarter. Hedge funds and other institutional investors own 90.30% of the company’s stock.
In related news, Director Woodrow A. Myers, Jr. sold 3,900 shares of the business’s stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $63.93, for a total transaction of $249,327.00. Following the completion of the transaction, the director now directly owns 11,500 shares in the company, valued at $735,195. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Timothy C. Wentworth bought 8,000 shares of Express Scripts Holding stock in a transaction that occurred on Tuesday, October 31st. The shares were acquired at an average price of $61.13 per share, with a total value of $489,040.00. Following the completion of the transaction, the chief executive officer now owns 98,628 shares of the company’s stock, valued at $6,029,129.64. The disclosure for this purchase can be found here. Over the last quarter, insiders have sold 6,284 shares of company stock worth $397,421. 0.68% of the stock is currently owned by corporate insiders.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Get a free copy of the Zacks research report on Express Scripts Holding (ESRX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.